Similar Papers

Paper Title
Journal
Date
Author
OP0187 IDENTIFYING A POPULATION OF PATIENTS FOR INTENSIVE FIRST-LINE THERAPY IN SLE: A CLINICAL AND BIOMARKER MODEL TO PREDICT THE NEED FOR INTENSIVE THERAPY
P Intapiboon ... M Y Md Yusof
Annals of the Rheumatic Diseases | VOL. 83
P Intapiboon, et. al.P Intapiboon ... M Y Md Yusof
01 Jun 2024
Pediatric Systemic Lupus Erythematosus: More Than a Positive Antinuclear Antibody
J E Weiss
Pediatrics in Review | VOL. 33
J E WeissJ E Weiss
01 Feb 2012
The clinical significance of low complement levels in patients with catastrophic antiphospholipid syndrome: A descriptive analysis of 73 patients from the "Catastrophic antiphospholipid syndrome registry".
Ana Ponce ... José M Basauli
Lupus | VOL. 31
Ana Ponce, et. al.Ana Ponce ... José M Basauli
10 Jun 2022
Nonstandard and adjunctive medical therapies for systemic lupus erythematosus
Robert W Mcmurray
Arthritis & Rheumatism | VOL. 45
Robert W McmurrayRobert W Mcmurray
01 Jan 2001
View more papers

More From: Lupus Science & Medicine

Paper Title
Journal
Date
Author
Ultrasonographic assessment of optic nerve: does it help in lupus-induced optic neuropathy?
Amira Elsonbaty ... Abdallah El-Sayed Allam
Lupus Science & Medicine | VOL. 12
Amira Elsonbaty, et. al.Amira Elsonbaty ... Abdallah El-Sayed Allam
20 Jan 2025
EXamining the feasibility of exerCisE to manage symptoms of Lupus (EXCEL): a protocol for a randomised controlled pilot study
Megan Quickfall ... Alex J Wadley
Lupus Science & Medicine | VOL. 12
Megan Quickfall, et. al.Megan Quickfall ... Alex J Wadley
16 Jan 2025
Postmarketing safety evaluation of belimumab: a pharmacovigilance analysis
Huqun Li ... Cuilian Guo
Lupus Science & Medicine | VOL. 12
Huqun Li, et. al.Huqun Li ... Cuilian Guo
09 Jan 2025
Interplay of NF-κB and PPAR-γ transcription factors in patients with juvenile systemic lupus erythematosus
Sinem Durmus ... Ozgur Kasapcopur
Lupus Science & Medicine | VOL. 12
Sinem Durmus, et. al.Sinem Durmus ... Ozgur Kasapcopur
08 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.